According to Inogen's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.505013. At the end of 2023 the company had a P/S ratio of 0.4054.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.4054 | -66.15% |
2022 | 1.20 | -44.51% |
2021 | 2.16 | -32.67% |
2020 | 3.21 | -22.93% |
2019 | 4.16 | -44.92% |
2018 | 7.55 | -24.21% |
2017 | 9.96 | 48.49% |
2016 | 6.71 | 34.52% |
2015 | 4.99 | -6.12% |
2014 | 5.31 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ResMed RMD | 7.12 | 1,309.32% | ๐บ๐ธ USA |
Masimo MASI | 3.52 | 596.05% | ๐บ๐ธ USA |
Chart Industries GTLS | 1.88 | 272.72% | ๐บ๐ธ USA |
Allied Healthcare Products AHPI | 0.0006 | -99.88% | ๐บ๐ธ USA |
Philips PHG | 0.9821 | 94.47% | ๐ณ๐ฑ Netherlands |